KIT and mastocytosis: Although KIT inhibitors showed very good inhibitory effects on mast cells in vitro, however, treatment with KIT inhibitors alone so far has been disappointing in most published clinical trials for mastocytosis [2, 5, 7–9], probably due to development of resistance to kinase inhibitors [5, 10].